A phase 3 study comparing a gel containing calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g (as dipropionate) With tacalcitol ointment (4 mcg/g) and gel vehicle, used once daily in the treatment of psoriasis vulgaris.

Trial Profile

A phase 3 study comparing a gel containing calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g (as dipropionate) With tacalcitol ointment (4 mcg/g) and gel vehicle, used once daily in the treatment of psoriasis vulgaris.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Apr 2015

At a glance

  • Drugs Betamethasone-dipropionate/calcipotriol (Primary) ; Tacalcitol
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors LEO Pharma
  • Most Recent Events

    • 05 Mar 2010 Secondary endpoint 'Psoriasis Area and Severity Index' has been met according to results presented at the 68th Annual Meeting of the American Academy of Dermatology.
    • 05 Mar 2010 Primary endpoint 'Disease control rate' has been met according to results presented at the 68th Annual Meeting of the American Academy of Dermatology.
    • 05 Mar 2010 Results presented at the 68th Annual Meeting of the American Academy of Dermatology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top